Abstract:BackgroundIn cases where a glycolysis inhibitor is not utilized, blood cells in vitro can consume glucose. Although current guidelines suggest using citrate-buffered inhibitors or ice-water slurry to mitigate this, practical and financial constraints often hinder adherence to these recommendations. Our objective was to evaluate the difference in glucose concentration in our routine sample management by employing Citrate buffered/NaF, NaF, and Gel Barrier tubes.MethodsIn this study, we utilized Greiner FCmix citrate-buffered NaF and EDTA tubes (3 mL), Becton Dickinson NaF and EDTA tubes (4 mL), and Becton Dickinson SSTII Gel Barrier tubes (5 mL). Following venipuncture, the tubes were transferred to the laboratory and centrifuged within 30 minutes. Glucose levels of 46 patients' samples were measured using a Cobas 6000 system (c501) employing the Glucose Hexokinase method, which exhibits an intermediate coefficient of variation (CV) of approximately 1.5% and no significant bias, as confirmed by monitoring with Biorad EQAS.ResultsThe mean plasma glucose difference between Citrate-buffered tubes and NaF tube samples was 2.8 mg/dL with a 95% confidence interval (CI) ranging from 2.2 to 3.4 mg/dL (Mean: 0.16 mmol/L; CI: 0.12 - 0.19 mmol/L). The difference in paired samples of NaF plasma and Gel Barrier tubes serum glucose was 3.2 mg/dL with a CI of 2.5 - 3.9 mg/dL (Mean: 0.18 mmol/L; CI: 0.14 - 0.22 mmol/L). Lastly, the mean difference in Citrate-buffered plasma and serum Gel barrier tubes for 46 paired samples was 6.0 mg/dL with a CI of 5.2 - 6.7 mg/dL (Mean: 0.33 mmol/L; CI: 0.29 - 0.37 mmol/L).ConclusionsFollowing guidelines, Citrate-buffered/NaF tubes demonstrate efficacy as glucose stabilizers. When compared to NaF tubes alone within a 30-minute timeframe, the mean difference between the two types of tubes was 2.8 mg/dL. Although NaF tubes are no longer recommended for glucose testing in plasma, they still outperform gel barrier serum tubes by 3.2 mg/dL. Furthermore, compared to citrate/NaF Plasma, serum glucose levels were on average 6.0 mg/dL lower. The preanalytical sample stage poses a significant obstacle to its reliable use for diagnostic or monitoring purposes. Laboratories should consider transitioning to Citrate/NaF tubes, or employ mathematical corrections if utilizing gel separator tubes for glucose testing in their established preanalytical process.

Influence of serum preparation with separating gel vacuum tubes on the determination results and stability of blood glucose,complement C3 and neuron specific enolase

Effects of physical and chemical factors in environment for dried blood spot preparation of neonatal screening assay

The Influence of Different Peripheral Venous Blood Sampling Methods on Hemolysis Rate in Emergency Room

Evaluation of BD Vacutainer SST™ II Plus Tubes for Special Proteins Testing

Evaluation of BD Vacutainer SST™ II Plus Tubes for Common Tumor Marker Tests by Roche Diagnostics Modular E 170 Analyzer

Evaluation of serum electrolytes measurement through the 6-year trueness verification program in China

Effects of different specimen pretreatment methods on the measurement of thyrotropin stimulating hormone in serum

A-060 Assessing Glucose Stability: A Comparison of Citrate/NaF, NaF, and Gel Separator Vacuum Tubes in Routine Medical Laboratory Practice

Five different levels of secondary standard reference material of transaminase prepared with mixed freezing human serum

A Comprehensive Stability Study of Glucose Concentrations Measured in Sodium Fluoride, Heparin and Serum Separator Tubes: A Cross-sectional Study

Pre-Analytical Sample Quality: Metabolite Ratios as an Intrinsic Marker for Prolonged Room Temperature Exposure of Serum Samples

Evalution on Blood Collection Tubes and Drug Additive with Free Hemoglobin in Plasm

Novel cholesterol efflux assay using immobilized liposome-bound gel beads: Confirmation and improvement for application in clinical laboratory

The Study of 5 Levels Serum Glucose Standard Reference Materials

Effects of glucose concentration fluctuation on proliferation,apoptosis and activity of endothelial nitric oxide synthase of endothelial progenitor cells

Investigation of precision and trueness of the glucose results from 15 measure systems in 4 domestic factories

Pre-processing stability of routine clinical chemistry analytes in a clotting tube; investigating the (un)suitability for at-home sample collection

Effects of Blood Collection Tubes on the Quantification of Catecholamines and Their O‐Methylated Metabolites by Liquid Chromatography Coupled With Tandem Mass Spectrometry

Impact of Blood Collection Tubes and Sample Handling Time on Serum and Plasma Metabolome and Lipidome

Assessing the stability of uncentrifuged serum and plasma analytes at various post-collection intervals

The stability of 65 biochemistry analytes in plasma, serum, and whole blood